Literature DB >> 22281090

Immunocytochemical diagnosis as inflammation by vitrectomy cell blocks in patients with vitreous opacity.

Toshihiko Matsuo1, Kouichi Ichimura.   

Abstract

PURPOSE: To describe the clinical and cytopathologic characteristics in patients with vitreous opacity of unknown cause or preceding inflammation, diagnosed cytopathologically as inflammation.
DESIGN: Retrospective case series. PARTICIPANTS: Forty-three consecutive patients (61 eyes) who underwent vitrectomy for vitreous opacity of unknown cause or preceding inflammation and were diagnosed cytopathologically with inflammation at one institution in 6 years from 2005 to 2010. During the same period, 11 consecutive patients with vitreous opacity of unknown cause were diagnosed cytopathologically with lymphoma (large B-cell lymphoma) and were excluded from the study.
METHODS: Cell blocks were made by centrifugation of vitrectomy fluid and embedded in paraffin for immunocytochemistry. MAIN OUTCOME MEASURES: Cytopathologic and immunocytochemical diagnosis using vitrectomy cell blocks.
RESULTS: Histiocytes (macrophages), small lymphocytes, neutrophils, and eosinophils were predominant cells, with no atypical large cells on hematoxylin-eosin staining. Immunocytochemically, most predominant cells were CD68-positive histiocytes (macrophages), followed by CD3-positive T cells, but CD20- or CD79a-positive B cells were rarely present. Epithelioid cells, positive for CD68, were found in 4 patients with or without an established diagnosis of sarcoidosis, and giant multinucleated cells were found in 2 patients with suspected preceding self-limiting Vogt-Koyanagi-Harada disease, based on the presence of depigmented red fundi. Inflammation was diagnosed in 2 patients with vitreous opacity who had a preceding onset of brain lymphoma or systemic lymphoma.
CONCLUSIONS: The presence of macrophages, combined with small T lymphocytes, was a major sign in intravitreal inflammation, manifesting as vitreous opacity. A simple technique of cytopathology and immunocytochemistry, using vitrectomy cell blocks, can be performed in most pathology laboratories.
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281090     DOI: 10.1016/j.ophtha.2011.10.020

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma.

Authors:  Takako Ito; Atsunobu Takeda; Kohta Fujiwara; Eiichi Hasegawa; Shintaro Nakao; Yoshihiro Ohishi; Yoshinao Oda; Hiroshi Yoshikawa; Koh-Hei Sonoda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-13       Impact factor: 3.117

2.  Are there primary intraocular lymphomas that do not develop into central nervous system lymphomas?

Authors:  Toshihiko Matsuo; Takehiro Tanaka
Journal:  J Clin Exp Hematop       Date:  2019-10-12

3.  A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet.

Authors:  Kayo Suzuki; Kenichi Namba; Keitaro Hase; Kazuomi Mizuuchi; Daiju Iwata; Takako Ito; Nobuyoshi Kitaichi; Hiroshi Takase; Susumu Ishida
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-29

4.  Utility of Liquid-Based Cytology and Cell Block Procedure Obtained by Vitrectomy to Diagnose Ocular Sarcoidosis-The Significance of Epithelioid Granuloma and Epithelioid Cells.

Authors:  Rintaro Ohe; Yutaka Kaneko; Hiroyuki Namba; Katsuhiro Nishi; Jun-Ichi Goto; Mitsuru Futakuchi; Koichi Nishitsuka
Journal:  Clin Ophthalmol       Date:  2022-10-10

5.  A flow cytometric analysis of vitreous inflammatory cells in patients with proliferative diabetic retinopathy.

Authors:  Mojca Urbančič; Veronika Kloboves Prevodnik; Daniel Petrovič; Mojca Globočnik Petrovič
Journal:  Biomed Res Int       Date:  2013-10-27       Impact factor: 3.411

6.  Discrimination of dissociated lymphoma cells from leukocytes by Raman spectroscopy.

Authors:  Yuko Iwasaki; Masahiko Kawagishi; Hiroshi Takase; Kyoko Ohno-Matsui
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.